Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease (Q83104034)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Impaired fibrinolytic activity in type II diabetes: correlation with urinary albumin excretion and progression of renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Robert William Schrier

6

object named as

Schrier RW

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Kamgar M

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Nobakhthaghighi N

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Shamshirsaz AA

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Estacio RO

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

McFann KK

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

English

0 references

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

1899-1903

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16598198%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000355

19 January 2020

exact match

0 references

cites work

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Microalbuminuria predicts mortality in non-insulin-dependent diabetics

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Prospective study of microalbuminuria as predictor of mortality in NIDDM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Bradykinin and renal fibrosis: have we ACE'd it?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Renal fibrosis: not just PAI-1 in the sky.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Vitronectin functions as a cofactor for rapid inhibition of activated protein C by plasminogen activator inhibitor-1. Implications for the mechanism of profibrinolytic action of activated protein C

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Global and societal implications of the diabetes epidemic

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Intensive blood pressure control reduces the risk of cardiovascular events in patients with peripheral arterial disease and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Role of the angiotensin AT(1) receptor in rat aortic and cardiac PAI-1 gene expression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Molecular characterization of angiotensin II--induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Salutary effects of attenuation of angiotensin II on coronary perivascular fibrosis associated with insulin resistance and obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Regression of glomerulosclerosis with high-dose angiotensin inhibition is linked to decreased plasminogen activator inhibitor-1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Plasminogen activator inhibitor-1 deficiency retards diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Independent relationship between microalbuminuria and plasminogen activator inhibitor-1 activity (PAI-1) activity in clinically healthy 58-year-old men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Increased plasma plasminogen activator inhibitor-1 levels: a possible marker of hypertensive target organ damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Increased plasma thrombin-activatable fibrinolysis inhibitor levels in normotensive type 2 diabetic patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Appropriate Blood Pressure Control in type II diabetes (ABCD Trial): implications for complications

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Baseline characteristics of participants in the Appropriate Blood Pressure Control in Diabetes trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021

Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000355

7 January 2021